Valuation: Perrigo Company

Market Cap 1.39B 1.22B 1.12B 1.05B 1.98B 131B 2.02B 13.53B 5.22B 64.86B 5.22B 5.11B 225B P/E 2026 *
-71.8x
P/E 2027 * 8.66x
Enterprise Value 4.33B 3.79B 3.5B 3.27B 6.15B 409B 6.29B 42.12B 16.26B 202B 16.26B 15.9B 701B EV / Sales 2026 *
1.07x
EV / Sales 2027 * 1.03x
Free-Float
99.61%
Yield 2026 *
11.5%
Yield 2027 * 11.8%
Manager TitleAgeSince
Chief Executive Officer 63 06/06/2026
Director of Finance/CFO 51 15/05/2022
Chief Operating Officer - 22/06/2025
Director TitleAgeSince
Director/Board Member 75 31/10/2014
Director/Board Member 61 06/11/2016
Director/Board Member 70 05/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.76%+9.21%+55.10%+157.81% 1,097B
-1.55%+6.97%+67.42%+54.51% 622B
-1.35%+7.63%+36.12%+87.54% 449B
-1.98%+6.34%+29.51%+24.01% 334B
-1.15%+4.90%+40.87%+26.43% 294B
+0.25%+2.97%+32.14%+41.20% 286B
+0.35%+3.14%-27.80%-42.26% 213B
-0.54%+3.63%+28.80%+61.97% 195B
-1.23%+0.20%+13.02%+62.59% 157B
Average -1.15%+6.79%+30.58%+52.64% 405.19B
Weighted average by Cap. -1.64%+8.72%+41.52%+78.64%

Financials

2026 *2027 *
Net sales 4.06B 3.55B 3.28B 3.06B 5.76B 383B 5.89B 39.46B 15.23B 189B 15.23B 14.9B 657B 4.1B 3.59B 3.31B 3.09B 5.82B 387B 5.96B 39.87B 15.39B 191B 15.39B 15.05B 664B
Net income -339M -297M -274M -256M -482M -32.05B -493M -3.3B -1.27B -15.81B -1.27B -1.25B -54.9B 161M 141M 130M 122M 229M 15.26B 235M 1.57B 606M 7.53B 606M 593M 26.14B
Net Debt 2.94B 2.57B 2.38B 2.22B 4.18B 278B 4.27B 28.59B 11.04B 137B 11.04B 10.79B 476B 2.83B 2.48B 2.29B 2.13B 4.02B 267B 4.11B 27.51B 10.62B 132B 10.62B 10.39B 458B
Logo Perrigo Company
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-